459 results on '"Sakaguchi, Takashi"'
Search Results
2. Site Formation Processes and Long-term Changes in Land Use among Maritime Hunter-Gatherers: A Case Study at the Hamanaka-2 Site, Rebun Island, Hokkaido
3. Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic
4. Inguinal Lymphadenopathy After Renal Transplantation Leading to the Diagnosis of Prostate Cancer: A Case Report
5. Skipping Breakfast and Progression of Chronic Kidney Disease in the General Japanese Population: the Iki City Epidemiological Study of Atherosclerosis and Chronic Kidney Disease (ISSA-CKD)
6. MP10-02 A NOVEL THERAPEUTIC TARGET SCG2 MIGHT COOPERATE WITH HIF1α IN TKI-RESISTANT RENAL CELL CARCINOMA
7. LncRNA BCYRN1 as a Potential Therapeutic Target and Diagnostic Marker in Serum Exosomes in Bladder Cancer.
8. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
9. Development of a novel treatment based on PKMYT1 inhibition for cisplatin-resistant bladder cancer with miR-424-5p-dependent cyclin E1 amplification
10. Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients
11. Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma
12. Successful Complete Resection and Recurrence-Free Outcome in Renal Cell Carcinoma with Vena Cava Tumor Thrombus: Neoadjuvant Immune Checkpoint Inhibitor (ICI)-Based Combination Therapies
13. Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor
14. Figure S1 from PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
15. Supplementary Table 2 from PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
16. Supplementary Table 1 from PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
17. Supplementary figure legends from PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
18. Data from PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma
19. Exosomal microRNA-1 and MYO15A as a target for therapy and diagnosis in renal cell carcinoma
20. Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?
21. A Case of Pyruvate Dehydrogenase Complex Deficiency Disease with Food Protein-Induced Enterocolitis Syndrome
22. Characterization and treatment of gemcitabine- and cisplatin-resistant bladder cancer cells with a Pan-RAS inhibitor
23. INTERACTIVE TIMETABLING SYSTEM WITH FUNCTION OF ESTIMATING TRAIN CONGESTION ON TIMETABLE PLANNED
24. Laparoscopic Surgery for Pheochromocytoma in Hemodialysis Patients
25. Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma
26. microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1
27. Mortuary Variability and Status Differentiation in the Late Jomon of Hokkaido Based on the Analysis of Shuteibo (Communal Cemeteries)
28. A Patient with Steroid-resistant Immunoglobulin A Vasculitis Treated Effectively with Diamino-diphenyl Sulfone
29. Site Formation Processes and Long-Term Changes in Land Use among Maritime Hunter-Gatherers: A Case Study at the Hamanaka-2 Site, Rebun Island, Hokkaido
30. Prediction Method of Train Delay Using Deep Learning Technique
31. Method for Extracting Knowledge of Train Rescheduling from Data of Operation Records
32. Defensibility of large prehistoric sites in the Mid-Fraser region on the Canadian Plateau
33. Erratum: Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer
34. Autopsy of Patient with Severe Motor and Intellectual Disabilities who Died from Hemorrhagic Shock Due to Submucosal Dissection of the Esophagus
35. Storage adaptations among hunter–gatherers: A quantitative approach to the Jomon period
36. Autoimmune pancreatitis associated with pancreatic cyst: how can we manage it?
37. Additional file 8 of EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
38. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids
39. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms
40. Building a New Pottery Chronology from the Late to Final Jomon of Central Hokkaido for Understanding the Emergence of Shuteibo
41. Refuse patterning and behavioral analysis in a pinniped hunting camp in the Late Jomon Period: A case study in layer V at the Hamanaka 2 site, Rebun Island, Hokkaido, Japan
42. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
43. Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
44. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH
45. Erratum to: Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study
46. Meloxicam as an adjuvant to peginterferon-α-2a and ribavirin treatment for genotype 1 chronic hepatitis C: A randomized trial
47. DEVELOPMENT OF THE SIGNAL ARRANGEMENT EVALUATION SYSTEM
48. Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma
49. Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant
50. Potential new therapy of Rapalink‐1, a new generation mammalian target of rapamycin inhibitor, against sunitinib‐resistant renal cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.